Benzocaine Gel
NDC Package 71888-101-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Benzocaine gel is uSES: For the temporary relief of discomfort and pain associated withminor burns and skin irritationsminor cuts and scrapesitchingDIRECTIONS: Adults and children 12 years of age and older: Apply to affected area not more than 3-4 times daily. This formulation utilizes a gel delivery system. Marketed by Bellus Medical, Llc, this product is identified by NDC 71888-101 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
71888-101-02
Package Description
12 PACKET in 1 BOX / 4 mL in 1 PACKET (71888-101-01)
Product Code
71888-101
11-Digit Billing Format
71888010102
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Benzocaine
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZOCAINE 200 mg/mL
Pharmacologic Class
Usage Information
USES: For the temporary relief of discomfort and pain associated withminor burns and skin irritationsminor cuts and scrapesitchingDIRECTIONS: Adults and children 12 years of age and older: Apply to affected area not more than 3-4 times daily.

Regulatory & Marketing

Labeler Name
Bellus Medical, Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-01-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71888-101-02 identifies a specific commercial package of 12 packet in 1 box / 4 ml in 1 packet (71888-101-01) of Benzocaine, a human over the counter drug labeled by Bellus Medical, Llc. This gel is formulated for topical use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bellus Medical, Llc on June 01, 2017. The current certification is valid through December 31, 2027.

How is this Bellus Medical, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71888010102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71888-101-02
11-Digit CMS (5-4-2)
71888-0101-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.